Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response

Nature Medicine

Volumn 2, Issue 12, 1996, Pages 1382-1385

  Friedman, Alon ^a,b   Kaufer, Daniela ^a   Shemer, Joshua ^b,c   Hendler, Israel ^b,c   Soreq, Hermona ^a   Tur Kaspa, Ilan ^b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Medical Corps   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG PENETRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

ACETYLTHIOCHOLINE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL MEMBRANE PERMEABILITY; CHOLINESTERASE INHIBITORS; EVOKED POTENTIALS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; HIPPOCAMPUS; MICE; MOLECULAR SEQUENCE DATA; PERSIAN GULF SYNDROME; PHYSOSTIGMINE; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDOSTIGMINE BROMIDE; RNA, MESSENGER; STRESS; TRANSCRIPTION, GENETIC;

ANIMALIA; TRIXIS;

EID: 0029850424     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1296-1382     Document Type: Article

References (28)

1. Taylor, P. Cholinergic agonists and Anticholinesterase agents. in The Pharmacological Basis of Therapeutics, 8th edn. (eds. Gilman, A.G., Rall, T.W., Nies, A.S. & Taylor, P.) 122-130, 131-147 (Pergamon, New York, 1990).
2. Deyi, X., Linxiu, W. & Shuqiu, P. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against soman poisoning in vivo. Fundam. Appl. Toxicol. 1, 217-221 (1981).
3. Diruhumber, P., French, M.C., Green, D.M., Leadbeater, L. & Stratton, J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharmacol. 31, 295-299 (1979).
4. Borland, R.G., Breman, D.H. & Nicholson, A.N. Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine). Hum. Toxicol. 4, 293-300 (1985).
5. Sharabi, Y. et al. Survey of symptoms following intake of pyridostigmine during the Persian Gulf War. Isr. J. Med. Sci. 27, 656-658 (1991).
6. Sharma, H.S., Cervos-Navarro, J. & Dey, P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10, 211-221 (1991).
7. Melia, K.M., Ryabinin, A.E., Schroeder, R., Bloom, F.E. & Wilson, M.C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J. Neurosci. 14, 5929-5938 (1994).
8. Ben Aziz-Aloya, R. et al. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos. Proc. Natl. Acad. Sci. USA 90, 2471-2475 (1993).
9. Blick, D.W. et al. Acute behavioral toxicity of pyridostigmine or soman in primates. Toxicol. Appl. Pharmacol. 126, 311-318 (1994).
10. Friedman, A. & Gutnick, M.J. Intracellular calcium and control of burst generation in neurons of guinea-pig neocortex in-vitro. Eur. J. Neurosci. 1, 374-381 (1989).
11. Glickson, M. et al. The influence of pyridostigmine on human neuromuscular functions - studies in healthy human subjects. Fundam. Appl. Toxicol. 16, 288-298 (1991).
12. Ekstrom, T.J., Klump, W.M., Getman, D., Karin, M. & Taylor, P. Promoter elements and transcriptional regulation of the acetylcholinesterase gene. DNA Cell Biol. 12, 63-72 (1993).
13. Ehrhart-Bornstein, M. et al. Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. J. Endocrinol. 131, 5-8 (1991).
14. Brust, P. Blood-brain-barrier transport under different physiological and pathophysiological circumstances including ischemia. Exp. Pathol. 42, 213-219 (1991).
15. Harik, S.I. & Kalaria, R.N. Blood-brain-barrier abnormalities in Alzheimer's disease. Ann. N. Y. Acad. Sci. 640, 47-52 (1991).
16. Agnoli, A., Martucci, N., Manna, V., Conti, L. & Fioravanti, M. Effect of cholinergic and anticholinergic drugs on short term memory in Alzheimer's dementia: A neuropsychological and computerized electroencephalographic study. Clin. Neuropharmacol. 6, 311-323 (1983).
17. Iwasaki, Y., Wakata, N. & Sinoshita, M. Parkinsonism induced by pyridostigmine. Acta Neurol. Scand. 78, 236 (1988).
18. Loewenstein-Lichtenstein, Y. et al. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nature Med. 1, 1082-1085 (1995).
19. Whittaker, M. Cholinesterases. Monogr. Hum. Genet. 65-85 (1986).
20. Schwarz, M., Click, D., Loewenstein, Y. & Soreq, H. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol. Ther. 67, 283-321 (1995).
21. Brown, D.A. Slow cholinergic excitation - a mechanism for increasing neuronal excitability. Trends Neurosci. 6, 302-306 (1983).
22. McEwen, B.S. & Sapolsky, R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5, 205-216 (1995).
23. Gavaghan, H. NIH panel rejects Persian Gulf syndrome. Nature 369, 8 (1994).
24. Ben-Nathan, D., Lustig, S. & Danenberg, H.D. Stress-induced neuroinvasiveness of a neurovirulent noninvasive Sindbis virus in cold or isolation subjected mice. Life Sci. 48, 1493-1500 (1991).
25. Neville, L.F., Gnatt, A., Padan, R., Seidman, S. & Soreq, H. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations. J. Biol. Chem. 265, 20735-20738 (1990).
26. Seidman, S. et al. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3′-terminal exons. Mol. Cell. Biol. 15, 2993-3002 (1995).
27. Uyama, O. et al. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cerebral Blood Flow Metab. 8, 282-284 (1988).
28. Rachinsky, T.L. et al. Molecular cloning of mouse acetylcholinesterase: Tissue distribution of alternatively spliced mRNA species. Neuron 5, 317-327 (1990).